Convicted fraudster Elizabeth Holmes welcomes second child and she's pushing to delay prison

• Holmes was sentenced to over 11 years in prison while pregnant with second child in November.
• In a court filing this week, her legal team said Holmes has "two young children," according to Mercury News.

A court filing last week has revealed that Theranos founder Elizabeth Holmes is now a mother of two, and she's seeking to delay her looming incarceration.

The 39-year-old was sentenced to over 11 years in prison, and is due to begin her sentence on April 27, but she and her legal team want to postpone that until her appeal process is finished, according to court documents obtained by The Mercury News this week.

The documents also state that Holmes is a mother of "two young children." In November, her romantic partner Billy Evans confirmed that she was pregnant with their second child. Holmes gave birth to her first child in July 2021 while awaiting trial for her charges.

Complimentary Tech Event

Transform talent with learning that works

Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More

While her legal team argues for extending her freedom, prosecutors say Holmes poses a flight risk and shouldn't be free past the day she's due to go to prison, per Mercury News.

The former CEO of Theranos was convicted of defrauding investors out of over $144 million in January 2022, and her appeal process could take a year or more to complete, according to the Mercury News report. District Judge Edward Davila recommended Holmes serve sentence in a minimum-security prison camp in Texas, but the decision is ultimately made by the US Bureau of Prisons.

Holmes — a Stanford University dropout — founded Theranos in 2003. The Palo Alto-based startup's mission was to run blood tests that could detect several medical conditions from just a small amount of blood. The company's valuation shot up to $9 billion before Holmes and fellow Theranos executives were charged with fraud in 2018.